Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis

NCT05136144 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Seborrheic Keratosis

Interventions

DRUG: SM-020

Sponsor

DermBiont, Inc.

Collaborators

[object Object]